ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,246.68
0.48%
US Tech 100
17,851.60
0.72%
다우존스 지수
39,558.11
0.32%
Bitcoin
61,603.52
-2.07%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Akoya BioSciences Inc (AKYA)

  7. Akoya BioSciences Inc (AKYA) 뉴스

AKYA

Akoya BioSciences (AKYA)

Akoya BioSciences Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AKYA
일자시간출처헤드라인심볼기업
2024/05/1405:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKYAAkoya BioSciences Inc
2024/05/1405:00GlobeNewswire Inc.Akoya Biosciences Reports First Quarter 2024 Financial ResultsNASDAQ:AKYAAkoya BioSciences Inc
2024/05/0921:00GlobeNewswire Inc.Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma PatientsNASDAQ:AKYAAkoya BioSciences Inc
2024/05/0621:00GlobeNewswire Inc.Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, MassachusettsNASDAQ:AKYAAkoya BioSciences Inc
2024/05/0221:00GlobeNewswire Inc.Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical WorkflowsNASDAQ:AKYAAkoya BioSciences Inc
2024/04/2305:05GlobeNewswire Inc.Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024NASDAQ:AKYAAkoya BioSciences Inc
2024/04/0521:00GlobeNewswire Inc.Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and ScaleNASDAQ:AKYAAkoya BioSciences Inc
2024/03/0507:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKYAAkoya BioSciences Inc
2024/03/0506:05GlobeNewswire Inc.Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial OutlookNASDAQ:AKYAAkoya BioSciences Inc
2024/03/0420:01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AKYAAkoya BioSciences Inc
2024/03/0211:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
2024/03/0211:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
2024/03/0211:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
2024/03/0211:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
2024/03/0211:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
2024/03/0211:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
2024/03/0211:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
2024/02/1223:11Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AKYAAkoya BioSciences Inc
2024/02/0906:05GlobeNewswire Inc.Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor ConferenceNASDAQ:AKYAAkoya BioSciences Inc
2024/01/1822:00GlobeNewswire Inc.Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other DiseasesNASDAQ:AKYAAkoya BioSciences Inc
2024/01/1106:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKYAAkoya BioSciences Inc
2024/01/1022:00GlobeNewswire Inc.Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory BoardNASDAQ:AKYAAkoya BioSciences Inc
2024/01/0905:57Dow Jones NewsAkoya Biosciences Shares Jump on 2024 Outlook, Thermo Fisher DealNASDAQ:AKYAAkoya BioSciences Inc
2024/01/0820:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKYAAkoya BioSciences Inc
2024/01/0722:00GlobeNewswire Inc.Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 OutlookNASDAQ:AKYAAkoya BioSciences Inc
2024/01/0722:00GlobeNewswire Inc.Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics WorkflowNASDAQ:AKYAAkoya BioSciences Inc
2024/01/0722:00GlobeNewswire Inc.Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine PlatformNASDAQ:AKYAAkoya BioSciences Inc
2024/01/0322:50Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AKYAAkoya BioSciences Inc
2023/12/2109:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKYAAkoya BioSciences Inc
2023/12/2022:05GlobeNewswire Inc.Akoya to Participate at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:AKYAAkoya BioSciences Inc
 검색 관련기사 보기:NASDAQ:AKYA

최근 히스토리

NASDAQ
TSLA
Tesla
CCOM
US30
US 30
AMEX
XLV
Health Care Select Sector
COIN
SOLUSD
Solana
USOTC
ADDYY
Adidas (QX)
NASDAQ
AAPL
Apple
USOTC
BASFY
BASF (QX)
NASDAQ
NVDA
NVIDIA
NYSE
BAC
Bank of America
AMEX
SPY
SPDR S&P 500
CCOM
US100
US Tech 100
NYSE
NKE
Nike
NYSE
XOM
Exxon Mobil
NYSE
AXP
American Express
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유